Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins
- PMID: 8472397
- DOI: 10.1007/BF00121168
Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins
Abstract
The level of 67 kDa laminin receptor (67LR) expression on breast and colon tumor cell surfaces was previously shown to be correlated with the capacity of tumor cells to metastasize. In the present work we investigate the effects of progestins and estrogen on the expression of 67LR in two sublines of the T47D human breast cancer cells: weakly tumorigenic, poorly invasive parental T47D cells and a highly tumorigenic, more invasive T47Dco subclone. Immunoblotting with an affinity purified antibody directed against a synthetic peptide recognizes the 67LR in these cells. 67LR expression in the T47Dco subclone is 5.5-fold higher than in their parental T47D cells. Treatment of T47D cells with 1 nM of the synthetic progestin R5020 results in a 4-fold increase in 67LR protein expression. Estrogen also induced 67LR expression, but only by 1.5-fold. The progestin-stimulated expression of the 67LR correlates with a 4.3-fold increase in attachment of T47D cells to laminin. A monoclonal antibody, mAb 13, directed against beta 1 integrin, completely blocks the attachment of T47D cells to fibronectin, only partially inhibits the attachment of T47D cells to laminin, and appears not to affect the progestin-stimulated laminin attachment of T47D cells. A new antiprogestin, ZK 112.993, significantly inhibits both progestin-stimulated 67LR expression and the increased attachment to laminin. These results suggest a possible role for progestin in mediating one of the multiple events thought to be important in metastasis of steroid receptor positive human breast cancer cells.
Similar articles
-
Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer.Curr Pharm Des. 2017;23(32):4745-4757. doi: 10.2174/1381612823666170710125332. Curr Pharm Des. 2017. PMID: 28699539 Review.
-
Effects of omega-3 fatty acids on progestin stimulation of invasive properties in breast cancer.Horm Cancer. 2012 Dec;3(5-6):205-17. doi: 10.1007/s12672-012-0118-6. Epub 2012 Jul 26. Horm Cancer. 2012. PMID: 22833172 Free PMC article. Review.
-
Expression of 32/67-kDa laminin receptor in laminin adhesion-selected human colon cancer cell lines.Br J Cancer. 1998;77(1):15-20. doi: 10.1038/bjc.1998.3. Br J Cancer. 1998. PMID: 9459140 Free PMC article.
-
Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines.J Natl Cancer Inst. 1989 May 10;81(10):781-8. doi: 10.1093/jnci/81.10.781. J Natl Cancer Inst. 1989. PMID: 2523976
-
Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells.Int J Cancer. 1992 Oct 21;52(4):653-7. doi: 10.1002/ijc.2910520426. Int J Cancer. 1992. PMID: 1399148
Cited by
-
Looking into laminin receptor: critical discussion regarding the non-integrin 37/67-kDa laminin receptor/RPSA protein.Biol Rev Camb Philos Soc. 2016 May;91(2):288-310. doi: 10.1111/brv.12170. Epub 2015 Jan 28. Biol Rev Camb Philos Soc. 2016. PMID: 25630983 Free PMC article. Review.
-
Quantitative proteomics: measuring protein synthesis using 15N amino acid labeling in pancreatic cancer cells.Anal Chem. 2009 Jan 15;81(2):764-71. doi: 10.1021/ac801905g. Anal Chem. 2009. PMID: 19072287 Free PMC article.
-
Diminution of 37-kDa laminin binding protein expression reduces tumour formation of murine lung cancer cells.Br J Cancer. 1999 Jun;80(8):1115-22. doi: 10.1038/sj.bjc.6690474. Br J Cancer. 1999. PMID: 10376960 Free PMC article.
-
Inhibition of experimental metastasis of human fibrosarcoma cells by anti-recombinant 37-kDa laminin binding protein antibody.Jpn J Cancer Res. 1999 Apr;90(4):425-31. doi: 10.1111/j.1349-7006.1999.tb00765.x. Jpn J Cancer Res. 1999. PMID: 10363581 Free PMC article.
-
Anti-invasion drugs.Breast Cancer Res Treat. 1996;38(1):121-32. doi: 10.1007/BF01803790. Breast Cancer Res Treat. 1996. PMID: 8825129 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical